Director

Benjamin J. Hindson

Chief Scientific Officer, President and Director·10x Genomics, Inc.

About

Benjamin J. Hindson co-founded 10x Genomics in July 2012 and has served as its Chief Scientific Officer and President since October 2012, and as a director since July 2012.

He served as the company's President of Technology and Treasurer from July 2012 until October 2012, and as its Secretary from October 2012 until April 2014.

Before co-founding 10x Genomics, he was Co-founder and Chief Scientific Officer of QuantaLife from August 2008 until its sale to Bio-Rad Laboratories in October 2011, and from 2002 to 2008 held various positions at Lawrence Livermore National Laboratory in the Chemical and Biological Weapons Non-proliferation Program.

He earned his B.Sc. in Chemistry and his Ph.D. in Chemistry from Deakin University, Australia.

Since 2012
Age 51
Tenure 14 yrs

Also at 10x Genomics, Inc.

SS Serge Saxonov Chief Executive Officer and Director JS John R. Stuelpnagel Chairman of the Board of Directors AM Alan Mateo Director KP Kimberly J. Popovits Director ST Sarah Teichmann Director SK Sri Kosaraju Director

Roles

Organization Role Dates Details
10x Genomics, Inc. Chief Scientific Officer, President and Director 2012–present Current role
10x Genomics President of Technology and Treasurer July 2012 - October 2012 Early leadership role before becoming CSO and President.
10x Genomics Secretary October 2012 - April 2014 Also served as corporate Secretary during the company's early years.
QuantaLife Co-founder and Chief Scientific Officer August 2008 - October 2011 Privately held life sciences company; sold to Bio-Rad Laboratories in October 2011.
Lawrence Livermore National Laboratory Various positions, Chemical and Biological Weapons Non-proliferation Program 2002 - 2008

Related

Company 10x Genomics, Inc. Company hub Person Serge Saxonov Chief Executive Officer and Director Person John R. Stuelpnagel Chairman of the Board of Directors Person Alan Mateo Director Person Kimberly J. Popovits Director Person Sarah Teichmann Director Person Sri Kosaraju Director Person Shehnaaz Suliman Director Person Adam S. Taich Chief Financial Officer Person Randy Wu General Counsel and Secretary Person Eric S. Whitaker Strategic Counsel (former Chief Legal Officer)
Source: 10x Genomics, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo